High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

Published:2022-12 Issue:8 Volume:27 Page:460-470
ISSN:2472-5552
Container-title:SLAS Discovery
language:en
Short-container-title:SLAS Discovery

Author:

Srinivasan Bharath^ORCID,Flórez Weidinger Juan Daniel,Zhai Xiang,Lemercier Guillaume,Ikeda Timothy^ORCID,Brewer Mark,Zhang Bairu,Heyse Stephan,Wingfield Jonathan,Steigele Stephan^ORCID

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference33 articles.

1. Impact of a five-dimensional framework on R&D productivity at AstraZeneca;Morgan;Nat Rev Drug Discov,2018

2. From targets to leads: the importance of advanced data analysis for decision support in drug discovery;Fischer;Curr Opin Drug Discov Dev,2005

3. Improving target assessment in biomedical research: the GOT-IT recommendations;Emmerich;Nat Rev Drug Discov,2021

4. Diagnosing the decline in pharmaceutical R&D efficiency;Scannell;Nat Rev Drug Discov,2012

5. Lead generation - enhancing the success of drug discovery by investing in the hit to lead process;Alanine;Comb Chem High Throughput Screen,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput kinetics in drug discovery;SLAS Discovery;2024-07

2. Non-equilibrium modalities of inhibition: Characterizing irreversible inhibition for the ErbB receptor family members;Methods in Enzymology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP